Low Dose CT Lung Cancer Screening Option for Qualified GE Systems
System, X-Ray, Tomography, Computed. 510(k) K151372, from Ge Medical Systems, LLC (Waukesha, WI). Product code JAK, class 2.
As of Nov 21, 2026, K151372 is an FDA 510(k) held by Ge Medical Systems, LLC, substantially equivalent on Aug 14, 2015 after 85 days, with no recalls tied to it in FDA's recall database.
- Review time: 85 days
- Recalls: 0
The Low Dose CT (LDCT) Lung Cancer Screening Option (LCS) for Qualified GE Systems is indicated for using low dose CT for lung cancer screening. The screening must be performed within the established inclusion criteria of programs/ protocols that have been approved and published by either a governmental body or professional medical society.
- Lightspeed 4.0 CT Scanner SystemK013561 · GE Medical Systems · Nov 8, 2001
- Lightspeed 7.0 CT Scanner SystemK040372 · Ge Medical Systems, LLC · Mar 1, 2004
- AVIEW Aorta MetricsK260391 · Coreline Soft Co., Ltd. · Oct 16, 2026
- CAS-One IRK261225 · Cascination AG · Sep 29, 2026
- BodyTom 64 (NL4100); OmniTom Elite (NL5000)K261125 · Samsung HME America, Inc., dba NeuroLogica Corp. · Sep 22, 2026
- SCENARIA View Phase 6.0K261229 · Fujifilm Corporation · Sep 18, 2026
- FCT iStream Phase 2K253836 · Fujifilm Corporation · Sep 4, 2026
- BodyTom Elite (NL4000)K253450 · NeuroLogica Corp., a Samsung Company · Jul 28, 2026
- CardIQ SuiteK253770 · GE Medical Systems SCS · Jul 21, 2026
- Enhanced Boundary for PCCTK253560 · Ge Medical Systems, LLC · Jun 24, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 21, 2015
- Review panel
- Radiology
- Regulation
- 21 CFR 892.1750
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files